News

Cambridge Neuroscientists involved in large multi-centre Alzheimer's study

The Medical Research Council and National Institute of Health Research have funded a £6.9 million study into preclinical Alzheimer’s disease (AD), which aims to detect markers of disease prior to the onset of symptoms.

Volunteers to the Deep and Frequent Phenotyping study, who will be drawn from UK Biobank and other cohorts linked to Dementias Platform UK, will undergo repeated assessments including cognitive testing, multimodal MRI, amyloid- and tau-PET, EEG/MEG, blood and CSF analyses.

The multi-site study is led by Professor Simon Lovestone at the University of Oxford and has a strong Cambridge input via Dr Dennis Chan (site lead, pictured), Professor James Rowe (MEG lead) and Professor Barbara Sahakian (cognition lead).

Further details on this study can be obtained from

http://www.mrc.ac.uk/news/browse/world-s-most-in-depth-study-to-detect-early-signs-of-alzheimer-s-disease/

Posted on 22/08/2016